Page last updated: 2024-09-03

desloratadine and Chronic Disease

desloratadine has been researched along with Chronic Disease in 40 studies

Research

Studies (40)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	19 (47.50)	29.6817
2010's	20 (50.00)	24.3611
2020's	1 (2.50)	2.80

Authors

Authors	Studies
Chen, W; Chen, X; Li, J; Liu, Z; Peng, C; Su, J; Zhang, W; Zhu, W	1
Ben Chibani, J; Helal, AN; Kassab, A; Leban, N; Maouia, A; Youssef, M	1
Yang, X; Zheng, D	1
Chaowattanapanit, S; Choonhakarn, C; Julanon, N	1
Chen, X; He, Y; Li, Q; Luo, Y; Yan, J; Yan, S	1
Chen, M; Chen, W; Chen, X; Li, F; Li, J; Li, Q; Liu, Z; Peng, C; Su, J; Yan, S; Zhang, J; Zhang, W; Zhu, W	1
Wang, J; Yan, X; Zhao, Y	1
Arribas Granados, MP; Francés, L; Leiva-Salinas, M; Marin-Cabanas, I; Silvestre, JF	1
Chen, M; Chen, W; Chen, X; Guo, A; He, Y; Li, J; Liu, Z; Su, J; Wen, S; Yan, S; Zeng, W; Zhang, C; Zhang, J; Zhao, Y; Zhou, H; Zhu, W	1
Barkai, L; Izquierdo, I; Maurer, M; Mezei, G; Mitha, E; Potter, P; Santamaría, E	1
Kennedy, DW	1
Bessis, D; Raison-Peyron, N; Reymann, V	1
Bin, L; Chen, M; Chen, W; Chen, X; Guo, A; He, Y; Leung, DY; Li, J; Liu, Z; Peng, C; Su, J; Yan, S; Yi, M; Zeng, W; Zhang, J; Zhang, W; Zhu, W	1
Ciebiada, M; Ciebiada, MG; DuBuske, LM; Gorski, P; Kmiecik, T	1
Finlay, AY; Guillet, G; Hauptmann, P; Jian, AM; Kapp, A; Maurer, M; Potter, PC	1
Auquier, P; Dreyfus, I; Grob, JJ; Ortonne, JP	3
Augustin, M; Ehrle, S	1
Baskan, EB; Budak, F; Erturk, E; Gul, OO; Hacioglu, S; Imamoglu, S; Kiyici, S	1
Bachert, C; Maurer, M	1
Church, DS; Church, MK; Dimitrov, V; Kraeva, S; Kralimarkova, T; Lazarova, C; Popov, TA; Popova, D; Staevska, M	1
Bérard, F; Boulinguez, S	1
Eigelshoven, S; Homey, B; Korkmaz, H	1
Chu, CY; Hong, JB; Hu, FC; Lee, HC	1
Chu, CY; Hong, JB; Lee, HC	1
Langner, C; Siegel, C; Thonhofer, R; Trummer, M	1
Monroe, EW	1
Bernstein, D; Finn, A; Guerrero, R; Monroe, E; Patel, P; Ratner, P	1
Colanardi, MC; Ferrannini, A; Nettis, E; Paradiso, MT	1
Di Lorenzo, G; Ditta, V; Esposito Pellitteri, M; Lo Bianco, C; Mansueto, P; Martinelli, N; Pacor, ML; Rini, GB	1
Elbirt, D; Rottem, M; Sthoeger, Z	1
DuBuske, LM	1
Boonen, H; De Swerdt, A; Decroix, J; Henrijean, A; Lachapelle, JM; Lecuyer, M; Roquet-Gravy, PP; Speelman, G; Suys, E; Vastesaeger, N	1
Amoruso, A; Cassano, N; D'Argento, V; Filieri, M; Filotico, R; Raho, G; Vena, GA	1
Lam, HC; Tong, MC; Van Hasselt, CA	1
DuBuske, L	1
Abdalla, AN; Khalaf, AT; Liu, XM; Sheng, WX; Tan, JQ	1
Gauger, A; Hein, R; Ring, J	1
Bronsky, E; Gauger, A; Hein, R; Miller, B; Ring, J	1

Reviews

6 review(s) available for desloratadine and Chronic Disease

Article	Year
Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies. Clinical drug investigation, 2010, Volume: 30, Issue:2 Topics: Activities of Daily Living; Adult; Anti-Allergic Agents; Chronic Disease; Female; Germany; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Nasal Obstruction; Pregnancy; Product Surveillance, Postmarketing; Pruritus; Rhinitis, Allergic, Seasonal; Sleep; Sneezing; Structure-Activity Relationship; Treatment Outcome; Urticaria	2010
[Diagnostic and physiopathological innovations related to chronic urticaria]. Annales de dermatologie et de venereologie, 2010, Volume: 137, Issue:5 Suppl 1 Topics: Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Autoantibodies; Autoimmune Diseases; Blood Coagulation; Chronic Disease; Drug Eruptions; Female; Histamine H1 Antagonists, Non-Sedating; Histamine Release; Humans; Iodide Peroxidase; Loratadine; Mast Cells; Middle Aged; Omalizumab; Penicillins; Urticaria	2010
Desloratidine for the treatment of chronic urticaria. Skin therapy letter, 2002, Volume: 7, Issue:8 Topics: Chronic Disease; Histamine H1 Antagonists; Humans; Loratadine; Urticaria	2002
Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:14 Topics: Adult; Aged; Animals; Anti-Inflammatory Agents; Asthma; Child; Child, Preschool; Chronic Disease; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Histamine H1 Antagonists, Non-Sedating; Humans; Infant; Loratadine; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria	2005
Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy. American journal of clinical dermatology, 2007, Volume: 8, Issue:5 Topics: Acetates; Adolescent; Adult; Child; Chronic Disease; Cyclopropanes; Drug Therapy, Combination; Histamine H1 Antagonists, Non-Sedating; Humans; Infant; Leukotriene Antagonists; Loratadine; Quality of Life; Quinolines; Sulfides; Urticaria	2007
Desloratadine in the treatment of chronic idiopathic urticaria. Allergy, 2001, Volume: 56 Suppl 65 Topics: Cholinergic Antagonists; Chronic Disease; Cytokines; Histamine H1 Antagonists; Humans; Loratadine; Severity of Illness Index; Time Factors; Treatment Outcome; Urticaria	2001

Trials

22 trial(s) available for desloratadine and Chronic Disease

Article	Year
Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria. The pharmacogenomics journal, 2020, Volume: 20, Issue:1 Topics: Adult; China; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Histamine H1; Severity of Illness Index; Sleepiness; Treatment Outcome; Urticaria	2020
CRP relevance in clinical assessment of chronic spontaneous urticaria Tunisian patients. Cutaneous and ocular toxicology, 2017, Volume: 36, Issue:4 Topics: Adult; Anti-Inflammatory Agents; Antioxidants; C-Reactive Protein; Catalase; Chronic Disease; Female; Glutathione Peroxidase; Glutathione Transferase; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Severity of Illness Index; Superoxide Dismutase; Tunisia; Urticaria; Young Adult	2017
Clinical observation on the therapeutic effect of desloratadine citrate disodium in the treatment of chronic urticaria and changes in IL4, IL18, IL23 and IL-33 levels before and after treatment. Pakistan journal of pharmaceutical sciences, 2017, Volume: 30, Issue:3(Special) Topics: Adolescent; Adult; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Interleukin-18; Interleukin-23; Interleukin-33; Interleukin-4; Loratadine; Male; Middle Aged; Urticaria; Young Adult	2017
Effects of Desloratadine Citrate Disodium on Serum Immune Function Indices, Inflammatory Factors and Chemokines in Patients with Chronic Urticaria. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2019, Volume: 29, Issue:3 Topics: Administration, Oral; Adult; Biomarkers; Chemokine CCL5; Chemokines; China; Cholinergic Antagonists; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukins; Loratadine; Male; Middle Aged; Reference Values; Treatment Outcome; Urticaria	2019
Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2016, Volume: 27, Issue:1 Topics: Age Factors; Child; Child, Preschool; Chronic Disease; Cyproheptadine; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hungary; Loratadine; Male; Quality of Life; Remission Induction; South Africa; Time Factors; Treatment Outcome; Urticaria	2016
Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. Journal of investigational allergology & clinical immunology, 2008, Volume: 18, Issue:5 Topics: Acetates; Adolescent; Adult; Aged; Cetirizine; Chronic Disease; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Interactions; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Quality of Life; Quinolines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides; Treatment Outcome	2008
Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. Allergy, 2009, Volume: 64, Issue:4 Topics: Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Pruritus; Quality of Life; Severity of Illness Index; Urticaria	2009
How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life. Allergy, 2009, Volume: 64, Issue:4 Topics: Adult; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Quality of Life; Urticaria	2009
Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity. Clinical and experimental dermatology, 2010, Volume: 35, Issue:6 Topics: Adolescent; Adult; Autoimmune Diseases; Chi-Square Distribution; Chronic Disease; Drug Combinations; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hypothyroidism; Interferon-gamma; Interleukin-10; Loratadine; Male; Middle Aged; Prospective Studies; Thyroxine; Treatment Outcome; Tumor Necrosis Factor-alpha; Urticaria; Young Adult	2010
The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. The Journal of allergy and clinical immunology, 2010, Volume: 125, Issue:3 Topics: Adult; Aged; Cetirizine; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Quality of Life; Urticaria; Young Adult	2010
A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria. Journal of the American Academy of Dermatology, 2010, Volume: 63, Issue:5 Topics: Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Pilot Projects; Sleep Stages; Urticaria	2010
Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. Journal of the American Academy of Dermatology, 2003, Volume: 48, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Child; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Urticaria	2003
Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2004, Volume: 34, Issue:9 Topics: Acetates; Administration, Oral; Adolescent; Adult; Aged; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Pruritus; Quality of Life; Quinolines; Severity of Illness Index; Sulfides; Treatment Outcome; Urticaria	2004
Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. The Journal of allergy and clinical immunology, 2004, Volume: 114, Issue:3 Topics: Acetates; Adolescent; Adult; Aged; Chronic Disease; Cyclopropanes; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Quinolines; Sulfides; Treatment Outcome; Urticaria	2004
[Desloratadine for chronic idiopathic urticaria]. Harefuah, 2005, Volume: 144, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Israel; Loratadine; Male; Middle Aged; Patient Satisfaction; Surveys and Questionnaires; Urticaria	2005
Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria. Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:3 Topics: Administration, Oral; Adult; Belgium; Chronic Disease; Drug Administration Schedule; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Quality of Life; Severity of Illness Index; Treatment Outcome; Urticaria	2006
Influence of desloratadine on oxidative stress markers in patients with chronic idiopathic urticaria. International journal of dermatology, 2006, Volume: 45, Issue:4 Topics: Adult; Aged; Biomarkers; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Severity of Illness Index; Superoxide Dismutase; Urticaria	2006
Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial. American journal of clinical dermatology, 2007, Volume: 8, Issue:1 Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Pruritus; Severity of Illness Index; Treatment Outcome; Urticaria	2007
Rhinitis symptoms and quality of life in patients with chronic perennial rhinitis treated with desloratadine. The Journal of laryngology and otology, 2007, Volume: 121, Issue:12 Topics: Adult; Chronic Disease; Endoscopy; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Prospective Studies; Quality of Life; Rhinitis, Allergic, Perennial; Severity of Illness Index; Treatment Outcome	2007
Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria. Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Dipyridamole; Drug Therapy, Combination; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Platelet Aggregation Inhibitors; Skin Tests; Treatment Outcome; Urticaria	2008
Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study. Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:1 Topics: Activities of Daily Living; Adult; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Outcome Assessment, Health Care; Quality of Life; Sleep; Treatment Outcome; Urticaria	2008
Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. International journal of dermatology, 2001, Volume: 40, Issue:1 Topics: Adolescent; Adult; Aged; Cholinergic Antagonists; Chronic Disease; Dizziness; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Headache; Humans; Loratadine; Male; Middle Aged; Pharyngitis; Pruritus; Respiratory Tract Infections; Treatment Outcome; Urticaria; Virus Diseases	2001

Other Studies

12 other study(ies) available for desloratadine and Chronic Disease

Article	Year
The treatment outcomes and dose de-escalation of desloratadine up-dosing in chronic spontaneous urticaria. International journal of dermatology, 2018, Volume: 57, Issue:4 Topics: Adult; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Maintenance Chemotherapy; Male; Middle Aged; Recurrence; Remission Induction; Retreatment; Retrospective Studies; Treatment Outcome; Urticaria; Young Adult	2018
[Association of CACNA1C gene genetic polymorphism with the susceptibility as well as prognosis for chronic spontaneous urticaria]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2018, Sep-28, Volume: 43, Issue:9 Topics: Calcium Channels, L-Type; Chronic Disease; Genetic Predisposition to Disease; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Polymorphism, Single Nucleotide; Prognosis; Retrospective Studies; Urticaria	2018
C-reactive protein (CRP) rs3093059C predicts poor mizolastine response in chronic spontaneous urticaria patients with elevated serum CRP level. Experimental dermatology, 2019, Volume: 28, Issue:3 Topics: Adolescent; Adult; Aged; Animals; Benzimidazoles; C-Reactive Protein; China; Chronic Disease; Chronic Urticaria; Female; Gene Expression; Genotype; HEK293 Cells; Histamine H1 Antagonists; Humans; Interleukin-6; Loratadine; Male; Middle Aged; Polymorphism, Single Nucleotide; Rats; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult	2019
Effectiveness and safety of omalizumab in a patient with chronic urticaria and hepatitis C. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:5 Topics: Anti-Allergic Agents; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Middle Aged; Omalizumab; Urticaria	2015
Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria. Journal of dermatological science, 2014, Volume: 76, Issue:3 Topics: Adolescent; Adult; Aged; Asian People; Benzimidazoles; Case-Control Studies; China; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Receptor, Anaphylatoxin C5a; Risk Factors; Treatment Outcome; Urticaria; Young Adult	2014
EDITORIAL. International forum of allergy & rhinology, 2015, Volume: 5, Issue:12 Topics: Animals; Carcinogenesis; Chronic Disease; Diagnosis, Differential; Histamine Antagonists; Humans; Loratadine; Nasal Lavage; Nasal Mucosa; Nose Neoplasms; Papilloma, Inverted; Publishing; Rhinitis, Allergic; Sinusitis; Th1-Th2 Balance	2015
Follicular Traction Urticaria: A New Form of Chronic Inducible Urticaria? Acta dermato-venereologica, 2017, 04-06, Volume: 97, Issue:4 Topics: Administration, Oral; Biopsy; Chronic Disease; Drug Administration Schedule; Female; Hair Follicle; Hair Removal; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Physical Stimulation; Risk Factors; Tablets; Terminology as Topic; Treatment Outcome; Urticaria; Young Adult	2017
Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine. The Journal of allergy and clinical immunology, 2017, Volume: 139, Issue:4 Topics: Adult; Chronic Disease; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; ORAI1 Protein; Polymorphism, Single Nucleotide; Urticaria	2017
Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:3 Topics: Activities of Daily Living; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Sleep; Urticaria; Young Adult	2009
[Omalizumab for therapy-resistant chronic urticaria with angioedema]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2010, Volume: 61, Issue:10 Topics: Adult; Angioedema; Anti-Allergic Agents; Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Chronic Disease; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Histamine H1 Antagonists, Non-Sedating; Humans; Immunoglobulin E; Leukocytosis; Loratadine; Male; Omalizumab; Prednisolone	2010
Chronic idiopathic urticaria in Taiwan: a clinical study of demographics, aggravating factors, laboratory findings, serum autoreactivity and treatment response. Journal of the Formosan Medical Association = Taiwan yi zhi, 2011, Volume: 110, Issue:3 Topics: Adolescent; Adult; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Taiwan; Treatment Outcome; Urticaria; Young Adult	2011
Mastocytic enterocolitis as a rare cause of chronic diarrhea in a patient with rheumatoid arthritis. Wiener klinische Wochenschrift, 2011, Volume: 123, Issue:9-10 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Biopsy; Chronic Disease; Diagnosis, Differential; Diarrhea; Drug Therapy, Combination; Enterocolitis; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Immunoglobulin E; Intestinal Mucosa; Loratadine; Male; Mast Cells; Mastocytosis; Methotrexate; Middle Aged; Ranitidine; Tryptases	2011